and up-to-date on our AI empowered digital cytology solutions.
.png)
The implementation of the AI-driven workflow resulted in significant improvements:
- Increased Speed: Pathologists reported a 30% to 50% increase in workflow speed, with the diagnosis of benign cases often reduced to mere seconds.
- Enhanced Sensitivity: The AI was slightly biased toward sensitivity, ensuring that atypical cells were prioritized for review.
- Objective Data: The system provides quantitative metrics for atypical and suspicious cells, removing subjectivity from the diagnostic process.
- Improved Efficiency: The reduction in screening time allowed the lab to free up capacity for growth without compromising accuracy.
Clinical use of AIxURO resulted in a 30–50% faster overall read time, improved sensitivity with moreobjective data for atypical cases, and a noticeably better user experience. The system is easy to use,avoids unnecessary features, integrates well with glass slides, and supports increased efficiency andgrowth in routine clinical practice.
- A total of 100 ThinPrep thyroid FNAC cases with established ground truth cytologic diagnoses (The Bethesda System for Reporting Thyroid Cytopathology) using a consensus of the original cytology report interpretation and the surgical pathology findings were analyzed:
- 5 TBS-I, 35 TBS-II, 15 TBS-III, 15 TBS-IV, and 30 TBS-VI cases
- Each case was digitized into single-layer whole-slide images (WSIs) using Leica AT2 or 3DHISTECH scanners.
- The AIxTHY algorithm was applied to identify abnormal cells and quantify cytomorphologic features on each WSI.
- Eight independent reviewers (3 cytopathologists, 5 cytologists) assessed each case under two arms, separated by a two-week washout period:
- Arm 1- Microscopy only
- Arm 2- AI-assisted digital review
- Performance Metrics: Comparison of study diagnosis with ground truth cytology diagnosis for two arms across 800 total reads.
- Diagnostic agreement for TBS categorization
- Reclassification of TBS category
- Binary reclassification of the TBS-I reads from microscopy by AI-assisted review
- In the Nondiagnostic (TBS-I) category, microscopy (Arm 1) achieved 80.0% (32/40) agreement with the ground truth, but to our surprise, AI-assisted review (Arm 2) reduced nondiagnostic calls to 57.5% (23/40).
- Agreement for indeterminate TBS-III cases increased from 29.2% (35/120) in the microscopy arm to 46.7% (56/120) in the AI-assisted review arm.
- Overall, TBS-I reads decreased from 10.0% (80/800) in microscopy to 6.8% (54/800) in AI-assisted review, representing a 32.5% relative reduction (26 fewer TBS-I interpretations).
- Binary reclassification of the 80 TBS-I reads from microscopy (TBS-II as negative; TBS-III+ as positive) showed that AI-assisted review 2 reclassified:
- 12 as negative (32.1% specificity gain) and
- 4 as positive (40.0% sensitivity gain),
- thereby improving overall diagnostic accuracy and interpretive confidence for previously indeterminate cases.
- AI-assisted review reduced nondiagnostic (TBS-I) interpretations originally rendered by microscopy and improved diagnostic accuracy in thyroid FNAC.
- By reclassifying TBS-I cases into actionable Bethesda categories, AIxTHY enhanced both specificity and sensitivity.
- Reassignment to a benign or malignant diagnoses expedites definitive care.
- These results highlight the potential of AIxTHY as an effective adjunct for digital cytology workflows, supporting more reliable and efficient thyroid FNAC interpretation.
- 100 urine cytology cases were selected, comprising 60 positive and 40 negative diagnoses for bladder cancer.
- Each slide was digitized into a whole-slide image (WSI) using a Hamamatsu S360 scanner.
- AIxURO was applied to detect abnormal urothelial cells and quantify cytomorphologic features on each WSI.
- Four cytologists independently reviewed all cases under microscopy and AI-assisted review (AIxURO) arms, separated by a washout period, and data was pooled for 400 reads/arm.
- Visual fatigue was assessed using the Computer Vision Syndrome Questionnaire (CVS-Q), which rates 16 ocular and visual symptoms by frequency and intensity (total score of 0–32; scores ≥6 indicate CVS).
- Performance Metrics: Comparison of study diagnosis with ground truth cytology diagnosis for two arms across 400 total read.
- Binary diagnostic accuracy (positive: AUC and above; negative: NHGUC)
- Mean diagnostic turnaround time (second)
- In CVS-Q evaluation, microscopy produced higher mean scores than AIxURO at both the first 50 (5.8 vs. 1.2) and last 50 (10.5 vs. 2.8) reads, indicating greater visual fatigue with microscopy.
- CVS-Q scores progressively increased during microscopy (the mean score: 1.8 to 10.5), reaching levels consistent with CVS, whereas only one reviewer exceeded the CVS threshold after 100 reads in AIxURO.
- These results indicate that AIxURO reduces both the likelihood and severity of visual fatigue.
- In diagnostic performance, AIxURO achieved higher sensitivity (0.975 vs. 0.867) and accuracy (0.960 vs. 0.890), with substantially shorter mean turnaround time (24.2 seconds vs. 80.3 seconds) compared with microscopy, indicating improved accuracy and efficiency with AI assistance.
- Compared with microscopy, AIxURO was associated with lower CVS-Q scores, reflecting reduced visual fatigue, along with higher diagnostic accuracy and shorter reporting times.
- These findings support integrating the AI platform into routine cytology practice to enhance user comfort, reduce occupational visual strain, and improve diagnostic performance.
- 14 positive (HGUC) urine cytology specimens (cytospin and ThinPrep) digitized with Leica Aperio AT2 scanner at 4 different scan modes:
- Mode A- Default automatic
- Mode B- Optimized automatic
- Mode C- Manually focused points of adjustment
- Mode D- Multilayer Z-stacking
- Performance metrics:
- Rate of successful scanning (total slides that obtain WSI files from scanner);
- Number of high risk cells detected by AI algorithm
- Coverage rate of high risk cells (detected high risk cells in one Z-layer divided by the total high risk cells detected in 21 Z-layer WSI per slide)
- Advanced scan modes increase successful slide scanning, but does not increase the average high risk cell detection or coverage rates
- More high risk cells were detected with TP than cytospin but with comparable coverage rates
- More Z-layers increased average high risk cell detection and coverage rates
Advanced scan modes improve the success rate of obtaining an optimal WSI and the number and coverage rate of high risk cells increases with multiple Z-layers. More high risk cells were detected on ThinPrep vs cytospin but this did not significantly affect the AI algorithm analytic results.
- 45 HGUC urine cytology slides and 45 negative (NHGUC) slides digitized into WSI and inferred by an AI-algorithm to identify potential cancer cells.
- 12, 24, 36, or 48 abnormal cell thumbnail images were order-ranked by AI and presented in a reviewer gallery
- 2 cytologists reviewed thumbnail images and rendered a diagnosis based on The Paris System for Reporting Urine Cytology 2.0 for each gallery set
- Concordance with microscopy performed for each gallery set, requiring an exact match (HGUC to HGUC, NHGUC to NHGUC)
- Concordance for HGUC was significantly improved by increasing the number of diagnostic cells in the gallery from 38.9% to 91.1%, but were slightly decreased for NHGUC specimens from 92.2% to 90%.
- The highest concordance rate (95.6%) was established at 36 gallery cell images, but was only slightly decreased with 48 images
36 thumbnail cell images provides the highest concordance for HGUC vs NHGUC diagnoses in urine cytology
- 104 urine cytology slides (70 NHGUC and 34 positive [AUC, SHGUC, HGUC]), with diagnostic confirmation by an expert panel
- Review of AI (deep learning algorithm)- inferred digital gallery images by 1 cytopathologist (CP) and 2 cytologists (CT), assigning cases to The Paris System (TPS 2.0) diagnostic categories (4 week washout period between Arm 1 and 3)
- Arm 1- Microscopic review of urine cytology glass slide by CP
- Arm 2- WSI review of slide by CP
- Arm 3- AI-assisted review of images by CP and CTs
- Performance Metrics:
- Comparison of diagnostic concordance with sensitivity, specificity, PPV, NPV and accuracy for CP and CTs against initial diagnosis
- Comparison of diagnostic concordance with sensitivity, specificity, PPV, NPV and accuracy between conventional microscopy and AI-assisted image review for the CP
Microscopic Glass Slide Review versus AI-Assisted Image Review (CP only)
- Sensitivity: 85.2% vs 91.2% (+5.9%)
- Specificity: 100% vs 100%
- PPV: 100% vs 100%
- NPV: 93. vs 95.9% (+2.6%)
- Accuracy: 95.2% vs 97.1% (+1.9%)
AI-Assisted Review (CTA, CTB and CP)
- Sensitivity: 76.5%, 79.4%, 91.2%
- Specificity: 100%, 98.6%, 100%
- PPV: 100%, 96.4%, 100%
- NPV: 89.7%, 90.8%, 95.9%
- Accuracy: 92.3%, 92.3%, 97.1%
AI-assisted diagnoses were comparable to expert panel consensus (sensitivity 76.5 – 91.2%) with high specificity (98.6-100%). AI-assisted interpretation showed better sensitivity, NPV, and accuracy than conventional microscopy.
- 14 positive (HGUC) urine cytology specimens (cytospin and ThinPrep) digitized with Leica Aperio AT2 scanner at 4 different scan modes:
- Mode A- Default automatic
- Mode B- Optimized automatic
- Mode C- Manually focused points of adjustment
- Mode D- Multilayer Z-stacking
- Performance metrics:
- Rate of successful scanning (total slides that obtain WSI files from scanner);
- Number of high risk cells detected by AI algorithm
- Coverage rate of high risk cells (detected high risk cells in one Z-layer divided by the total high risk cells detected in 21 Z-layer WSI per slide)
- Advanced scan modes increase successful slide scanning, but does not increase the average high risk cell detection or coverage rates
- More high risk cells were detected with TP than cytospin but with comparable coverage rates
- More Z-layers increased average high risk cell detection and coverage rates
Advanced scan modes improve the success rate of obtaining an optimal WSI and the number and coverage rate of high risk cells increases with multiple Z-layers. More high risk cells were detected on ThinPrep vs cytospin but this did not significantly affect the AI algorithm analytic results.
- 131 urine cytology slides digitized and analyzed with AI-assisted algorithm for detecting and ranking abnormal urothelial cells using criteria from The Paris System (TPS2.0); ground truth diagnosis established by an expert panel
- Two arm study with 1 cytopathologist (CP) in both arms and 2 cytologists (CT) in the AI-assisted Arm 2
- Arm 1: CP review of urine cytology glass slide with diagnosis (4 week washout period)
- Arm 2: CP and CT review of AI-assisted inferred WSI of urine cytology slide with quantitative data statistics
- Performance Metrics: Comparison of research TPS diagnosis with expert diagnosis and calculation of sensitivity, specificity, PPV, NPV and accuracy
- Conventional Microscopy vs AI-Assisted Interpretation
- Sensitivity: 87% vs 92.3% (+5.1)
- Specificity: 100% vs 100%
- PPV: 100% vs 100%
- NPV: 94.8% vs 96.8% (+2.0)
- AI-Assisted Microscopy, CTA vs CTB vs CP interpretation
- Sensitivity: 79.55 VS 82.1% VS 92.3%
- Specificity: 100% vs 98.9% vs 100%
- PPV: 100% vs 97% vs 100%
- NPV: 92% vs 92.9% vs 96.8%
- ĸ (95% CI): 0.845 vs 0.847 vs 0.994
Ai-assisted interpretation was comparable to the expert consensus diagnosis, with superior sensitivity and NPV. AI-assisted interpretations showed near perfect agreement with the expert consensus diagnosis (ĸ = 0.944) and the microscopic diagnosis (ĸ = 0.862).
- Develop a machine-learning-based artificial intelligence (AI) model to assist monitoring morphologic changes in human embryonic stem cells (hESC) in color, using bright field microscopy images
- Pilot Study: Train the model to estimate degree of stem cell differentiation at the Hepatic Progenitor Cell (HPC stage), the critical checkpoint for hepatocyte differentiation, based on cellular morphologic features
- Initial training set: Expert annotated images of 341 successful HPC differentiations and 366 failed HPC differentiations
- Cross-validation set: Images of 86 successful and 51 failed HPC results
- Test set: Images of 64 successful and 29 failed HPC results
- Failed differentiation = no differentiation or differentiation into non-hepatocyte tissue types
- Performance Metrics: Accuracy and F1 scores of test set
The AI model showed excellent performance compared with the conventional method of determining degree of hepatocyte differentiation
- Accuracy = 0.978
- F1 score = 0.975
AI-assisted models have the potential to improve the detection of degrees of hepatocyte differentiation, thereby improving the efficiency of a manual process that is very time-intensive.
- Descriptive study using deidentified urine cytology slides digitized into WSI
- Artificial intelligence model training on slides with “active learning” to improve results
- Annotated WSI initially used to train computational model, then expert review of results with feedback to the model to learn.
- Sequence was repeated until satisfactory results were achieved
- AI deep-learning model was able to differentiate nucleus from cytoplasm to calculate N/C ratio using whole slide images (WSI)
- The model correctly provided statistical data (N/C ratio and nuclear size) on cells and successfully categorized them as atypical (NHGUC or AUC) or suspicious (SHGUC or HGUC) cells
AI-assistance for interpreting urine cytology using The Paris System for Reporting Urine Cytology has the potential to enhance abnormal cell detection and diagnostic concordance.
- Development of an automated deep-learning AI model for circulating tumor cell (CTC) analysis and enumeration
- Fluorescent microscopy CTC images (CK+/CD45-/DAPI+) collected from blood samples of non-small cell lung carcinoma patient by CMx CTC capture platform
- AI model developed with active learning implemented to train after expert image annotation on 20 slides and validation with 4 extra images
- 18 new test images studied for performance
- AI model predicted 34% more total CTC than current methods (1775 vs 1328)
- AI model recovered 45% more total CTCs absent from original human annotation (2507 vs 1732 events)
- AI model produced 90% time savings over conventional methods of enumeration (< 20 min vs approximately 4 hours)
- The model correctly characterized features of circulating tumor microthrombi (CTM), including CTC clusters and CTC-associated immune cells
An AI model trained to detect and enumerate circulating tumor cells in nonsmall cell lung cancer patients outperformed semiautomated methods, with higher sensitivity and significantly reduced review time (less than 20 minutes) for CTC enumeration in lung cancer specimens.
- Development of a deep-learning based image analysis model for cell classification and enumeration in urine cytology
- De-identified whole slide images (WSI) digitized and “active learning” approach used to train the model
- 3 sub-images (3335 cells) annotated by 3 domain experts for initial training
- Cells classified into 7 categories: High grade urothelial carcinoma (HGUC), cluster HGUC, atypical neoplastic cell, atypical reactive cell, inflammatory cell, epithelial cell, and unidentified cell, with expert feedback to the model
- Pilot study after training involved 2 sub-images from 5 digital slides (10 total sub-images)
- Ai model successfully learned the morphologies of all 6 cell types and was able to quantify total cell counts in each class
An artificial intelligence model that enumerates and classifies abnormal urothelial cells may improve urine cytology throughput, accuracy and reproducibility.

